Although recent advances in stem-cell research hold promisefor therapeutic use, this promise has been accompanied by social,political, economic, legal, religious, and ethical questions.These questions have touched a raw nerve, and numerous lawsand regulations have been implemented or are being consideredin order to control the use and spread of this new technology.The legal situation is particularly complex in Europe, whereeach country is governed through both national legislation andthe international European legislation passed by the EuropeanUnion. Since there are deep social and political disparitiesamong countries within the union that stem in part . . . [Full Text of this Article]
Production and Use of Embryos in Research and Therapy
Commercialization of Embryos
Summary
References
Related Letters:
Therapeutic Cloning
Pellegrino E. D., Kilner J. F., FitzGerald K. T., Bevington L. K., Mitchell C. B., Koop C. E., Meilaender G., Guenin L. M., Donaldson L., Schenk T. M., Weissman I. L., Evers K., Annas G. J.
Extract |
Full Text |
PDF
N Engl J Med 2002;
347:1619-1622, Nov 14, 2002.
Correspondence
This article has been cited by other articles:
Philipson, L.
(2005). Medical Research Activities, Funding, and Creativity in Europe: Comparison With Research in the United States. JAMA
294: 1394-1398
[Full Text]
Jennings, C. P.
(2005). From Science to Politics: The Stem Cell Debate. Policy Politics Nursing Practice
6: 3-4
Pellegrino, E. D., Kilner, J. F., FitzGerald, K. T., Bevington, L. K., Mitchell, C. B., Koop, C. E., Meilaender, G., Guenin, L. M., Donaldson, L., Schenk, T. M., Weissman, I. L., Evers, K., Annas, G. J.
(2002). Therapeutic Cloning. NEJM
347: 1619-1622
[Full Text]
Annas, G. J.
(2002). Cloning and the U.S. Congress. NEJM
346: 1599-1602
[Full Text]
Previous
